about
Regulation of the metastatic cell phenotype by sialylated glycansProtein modifications as potential biomarkers in breast cancer.Sialyl-tn in cancer: (how) did we miss the target?Sweetening the pot: adding glycosylation to the biomarker discovery equationTumour-associated carbohydrate antigens in breast cancer.The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer.Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery.Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccinesSynthetic and immunological studies of 5'-N-phenylacetyl sTn to develop carbohydrate-based cancer vaccines and to explore the impacts of linkage between carbohydrate antigens and carrier proteinsGlycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion.Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin RatiosDevelopment of antimetastatic drugs by targeting tumor sialic acids.Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against CancerSilencing of ST6GalNAc I suppresses the proliferation, migration and invasion of hepatocarcinoma cells through PI3K/AKT/NF-κB pathway.Efficient chemoenzymatic synthesis of sialyl Tn-antigens and derivatives.RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.Tyramide signal amplification for antibody-overlay lectin microarray: a strategy to improve the sensitivity of targeted glycan profiling.New mutations in C1GALT1C1 in individuals with Tn positive phenotype.ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.Synthetic and Immunological Studies of sTn Derivatives Carrying 5-N-(p-Substituted Phenylacetyl)Sialic Acid for the Development of Effective Cancer Vaccines.MMP-7 as a prognostic marker in colorectal cancer.Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma.Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids
P2860
Q27027559-C5F441B9-E401-40F6-B2F0-0DE6447186AAQ33586407-3E8FE98D-7FEC-4E4C-A53E-DE2813CEBB5BQ33649572-F747294C-7C45-4126-BAE0-50312A7D76C8Q33768460-AE85BF02-99D5-4665-927E-F8C31CF7FC5DQ34048052-729CE8E9-AC4C-47CD-9855-06531E681CBDQ34471553-D313100F-4EAA-4550-8F06-0B53F1B42B67Q35692128-C9AD81D9-ED49-4CBB-8766-3E83BF1BDF5EQ36868822-282B2109-0942-4C38-B42E-CDB1E1E2F2F4Q37120643-8F141314-A01A-40B2-9CEA-6460A192C246Q37487019-0FE614E4-FA61-4F32-9747-6981848A3BB9Q37512647-17C6EAB6-8136-477C-A828-590C8F0AB0E4Q37738102-AC5B1998-2023-4E8E-97C7-8EDE68BEB9A8Q38046212-99D5503F-34B9-4FA7-B9DB-AC4F76E28681Q38544783-02E75E45-050D-4551-B8C7-0D50B0A5F1FEQ38737068-A692AF0C-9216-495F-8871-64ED61E76D44Q38828915-F0C362A3-42EA-457C-9EBF-11B3A9AD60F9Q38926234-17FF4AB8-BB22-41E7-B4A9-97E0C27C8C7BQ39169405-3F499BD0-8CDB-4116-81AC-918679B85E61Q39623545-1D66BD45-A174-430C-B975-D26DC2419342Q39974401-6E44CA24-4BDF-4BD6-8EA8-9E1B7153180EQ40379188-635ACA84-B53F-428A-A03C-90E85813AE5EQ41809862-B4B0075D-0C56-4C9B-96D6-9655FFB1E594Q45177603-0CE4ED95-09F0-47E9-B718-8E14F73B8578Q49590854-4443CBEE-E77D-4084-8B58-CAFA9D1A28A0Q57169347-B8BDFAC8-C332-49BD-AAE2-DFF224EDEF4F
P2860
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
STn and prognosis in breast cancer.
@en
STn and prognosis in breast cancer.
@nl
type
label
STn and prognosis in breast cancer.
@en
STn and prognosis in breast cancer.
@nl
prefLabel
STn and prognosis in breast cancer.
@en
STn and prognosis in breast cancer.
@nl
P2093
P356
P1433
P1476
STn and prognosis in breast cancer
@en
P2093
K von Boguslawski
M Leivonen
S Nordling
P304
P356
10.1159/000055337
P50
P577
2001-01-01T00:00:00Z